Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case-control study

被引:1
|
作者
Cao, Yanyan [1 ]
Rhoads, Anthony [1 ]
Burns, Trudy [1 ]
Carnahan, Ryan M. [1 ]
Conway, Kristin M. [1 ]
Werler, Martha M. [2 ,3 ]
Mitchell, Allen [2 ]
Romitti, Paul [1 ]
机构
[1] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA
[2] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA
[3] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA
来源
BMJ OPEN | 2021年 / 11卷 / 12期
关键词
epidemiology; obstetrics; toxicology; ASPARTATE RECEPTOR ANTAGONISTS; AVIAN EMBRYO; DEVELOPMENTAL TOXICITY; DEXTROMETHORPHAN; TERATOGENESIS; PREVENTION; EXPOSURE; RISK;
D O I
10.1136/bmjopen-2021-053604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine associations between maternal use of cough medications containing dextromethorphan (DM) without guaifenesin (glyceryl guaiacolate (GG)) ('DM alone'), GG without DM ('GG alone') or DM +GG and major birth defects in offspring. Design Population-based case-control study. Setting The multisite, US National Birth Defects Prevention Study. Participants Mothers of 1644 children with neural tube defects (NTDs), 15 110 with non-NTDs, and 10 671 control children without a birth defect diagnosis. Main outcome measures ORs and 95% CIs. Results For NTD analysis, 1.7% of mothers of case children and 1.2% of mothers of control children reported using DM alone, 1.1% and 0.6% GG alone, and 0.4% and 0.2% DM +GG. Respective percentages for non-NTD analysis were 2.2% and 1.9% for DM alone, 1.7% and 1.6% for GG alone, and 0.5% and 0.4% for DM +GG. For all NTDs and subtypes, adjusted OR estimates for DM alone were near the null with 95% CIs that included 1.0. Estimates (95% CI) were 1.8 (1.0 to 3.3) for GG alone and 1.8 (0.6 to 4.8) for DM +GG with all NTDs and 2.2 (1.1 to 4.3) for GG alone with spina bifida. Of the 45 adjusted OR estimates for non-NTDs, 39 ranged from 0.5 to 1.6 with 95% CIs that included 1.0. Near twofold or higher estimates (95% CI) were observed for the remainder and included 1.9 (1.0 to 3.7) for hydrocephalus, 2.9 (1.3 to 6.5) for atrioventricular septal defect and 1.8 (1.1 to 3.0) for transverse limb deficiency with DM alone; 2.1 (1.1 to 4.0) for small intestinal atresia/stenosis and 2.1 (0.9 to 4.5) for omphalocele with GG alone; and 3.2 (1.5 to 6.9) for gastroschisis with DM +GG. Conclusions Maternal use of medications containing DM alone, GG alone or DM +GG showed positive associations with a small number of birth defects. These observations, which should be interpreted with caution due to small proportions of exposed mothers, may represent true signals or chance findings and warrant evaluation in future studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects
    Anderson, Kayla N.
    Lind, Jennifer N.
    Simeone, Regina M.
    Bobo, William V.
    Mitchell, Allen A.
    Riehle-Colarusso, Tiffany
    Polen, Kara N.
    Reefhuis, Jennita
    [J]. JAMA PSYCHIATRY, 2020, 77 (12) : 1246 - 1255
  • [2] Use of antihistamine medications during early pregnancy and selected birth defects: The National Birth Defects Prevention Study, 1997-2011
    Hansen, Craig
    Desrosiers, Tania A.
    Wisniewski, Kathy
    Strickland, Matthew J.
    Werler, Martha M.
    Gilboa, Suzanne M.
    [J]. BIRTH DEFECTS RESEARCH, 2020, 112 (16): : 1234 - 1252
  • [3] Maternal early pregnancy use of specific antidepressant medications and risk for birth defects
    Anderson, Kayla N.
    Lind, Jennifer N.
    Simeone, Regina
    Bobo, William V.
    Riehle-Colarusso, Tiffany
    Polen, Kara N.
    Reefhuis, Jennita
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 367 - 368
  • [4] Use of antidepressant medications during pregnancy: a multisite study
    Andrade, Susan E.
    Raebel, Marsha A.
    Brown, Jeffrey
    Lane, Kimberly
    Livingston, James
    Boudreau, Denise
    Rolnick, Sharon J.
    Roblin, Douglas
    Smith, David H.
    Willy, Mary E.
    Staffa, Judy A.
    Platt, Richard
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (02) : 194.e1 - 194.e5
  • [5] Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study
    Yang, J.
    Carmichael, S. L.
    Canfield, M.
    Song, J.
    Shaw, G. M.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (02) : 145 - 154
  • [6] Maternal dietary diversity during pregnancy and congenital heart defects: a case-control study
    Jiaomei Yang
    Yue Cheng
    Lingxia Zeng
    Shaonong Dang
    Hong Yan
    [J]. European Journal of Clinical Nutrition, 2021, 75 : 355 - 363
  • [7] Maternal dietary diversity during pregnancy and congenital heart defects: a case-control study
    Yang, Jiaomei
    Cheng, Yue
    Zeng, Lingxia
    Dang, Shaonong
    Yan, Hong
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2021, 75 (02) : 355 - 363
  • [8] Maternal Dietary Patterns during Pregnancy and Congenital Heart Defects: A Case-Control Study
    Yang, Jiaomei
    Kang, Yijun
    Cheng, Yue
    Zeng, Lingxia
    Yan, Hong
    Dang, Shaonong
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (16)
  • [9] Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study
    Huber, John C., Jr.
    Brender, Jean D.
    Zheng, Qi
    Sharkey, Joseph R.
    Vuong, Ann M.
    Shinde, Mayura U.
    Griesenbeck, John S.
    Suarez, Lucina
    Langlois, Peter H.
    Canfield, Mark A.
    Romitti, Paul A.
    Weyer, Peter J.
    [J]. NUTRITION JOURNAL, 2013, 12
  • [10] Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study
    John C Huber
    Jean D Brender
    Qi Zheng
    Joseph R Sharkey
    Ann M Vuong
    Mayura U Shinde
    John S Griesenbeck
    Lucina Suarez
    Peter H Langlois
    Mark A Canfield
    Paul A Romitti
    Peter J Weyer
    [J]. Nutrition Journal, 12